BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
News | 02. 11. 2013
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
